GSK and Theravance announced positive data from a Phase II study of the dual acting muscarinic antagonist and beta 2...
Allarity Therapeutics, Inc. announced the early discontinuation of its Phase II clinical trial of stenoparib, a novel PARP inhibitor, for the treatment of advanced recurrent ovarian cancer
Amgen announces the results of a Phase II trial evaluating the safety and efficacy of Brodalumab (formerly AMG 827) in...
There have been positive headline results from the Phase II clinical trial of EMA 401 from Spinifex Pharmaceuticals, in Postherpetic...
Boston Scientific Corporation has completed enrolment in the EVOLVE II randomized, controlled clinical trial. The EVOLVE II trial is designed...
Second Sight Medical announced positive three year results post-implant of its Argus II Retinal Prosthesis System from a multi-center clinical...
Idenix Pharmaceuticals has reported positive data from both an interim analysis of a Phase II study of its drug candidate...
La Jolla Pharmaceutical Company announced that results of the ATHOS-3 (Angiotensin II for the Treatment of High-Output Shock) Phase III...
New results from a Phase II study demonstrated that more than 90% of the patients with Glioblastoma multiforme (GBM) treated...